Pure Global
NCT03835078

Performance of Aspheric Hydrogel Lenses After a Refit With Sphere Silicone Hydrogel Lenses for 4 Weeks

Coopervision, Inc.·ClinicalTrials.gov·device·Device trialCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Ametropia
Drug/Device/Intervention
methafilcon A contact lenses
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Coopervision, Inc.
Location
Mexico City, Mexico
Timeline & enrollment
Phase
N/A
Start date
Jan 01, 2019
End date
Jul 06, 2019
Enrollment
42 participants
Primary outcome

Percentage of Participants With Lens Centration Assessment by the Investigator - Methafilcon A Contact Lenses,Percentage of Participants With Lens Centration Assessment by the Investigator - Methafilcon A Contact Lenses,Percentage of Participants With Lens Centration Assessment by the Investigator - Fanfilcon A Contact Lenses,Percentage of Participants With Lens Centration Assessment by the Investigator - Fanfilcon A Contact Lenses,Percentage of Participants With Lens Centration Assessment by the Investigator - Fanfilcon A Contact Lenses,Percentage of Participants With Corneal Coverage Assessment by the Investigator - Methafilcon A Contact Lenses,Percentage of Participants With Corneal Coverage Assessment by the Investigator - Methafilcon A Contact Lenses,Percentage of Participants With Corneal Coverage Assessment by the Investigator - Fanfilcon A Contact Lenses,Percentage of Participants With Corneal Coverage Assessment by the Investigator - Fanfilcon A Contact Lenses,Percentage of Participants With Corneal Coverage Assessment by the Investigator - Fanfilcon A Contact Lenses,Post-blink Movement Assessment by the Investigator - Methafilcon A Contact Lenses,Post-blink Movement Assessment by the Investigator - Methafilcon A Contact Lenses,Post-blink Movement Assessment by the Investigator - Fanfilcon A Contact Lenses,Post-blink Movement Assessment by the Investigator - Fanfilcon A Contact Lenses,Post-blink Movement Assessment by the Investigator - Fanfilcon A Contact Lenses,Lens Tightness Assessment by the Investigator - Methafilcon A Contact Lenses,Lens Tightness Assessment by the Investigator - Methafilcon A Contact Lenses,Lens Tightness Assessment by the Investigator - Fanfilcon A Contact Lenses,Lens Tightness Assessment by the Investigator - Fanfilcon A Contact Lenses,Lens Tightness Assessment by the Investigator - Fanfilcon A Contact Lenses,Overall Lens Fit Acceptance by the Investigator - Methafilcon A Contact Lenses,Overall Lens Fit Acceptance by the Investigator - Methafilcon A Contact Lenses,Overall Lens Fit Acceptance by the Investigator - Fanfilcon A Contact Lenses,Overall Lens Fit Acceptance by the Investigator - Fanfilcon A Contact Lenses,Overall Lens Fit Acceptance by the Investigator - Fanfilcon A Contact Lenses

Summary

The aim of this prospective study is to evaluate the clinical performance of habitual wearers
 of methafilcon A aspheric lenses after a refit with fanfilcon A sphere lenses for 4 weeks of
 daily wear.

ICD-10 classifications
Amblyopia ex anopsiaAmoebiasisAmoebiasis, unspecifiedMyoclonusOesophagitis
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT03835078
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT03835078 through Pure Global AI's free database. This phase not specified trial is sponsored by Coopervision, Inc. and is currently Completed. The study focuses on Ametropia. Target enrollment is 42 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.